Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Dark Comedy
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Music
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Thriller
Truck Series (TRUCK)
True Crime
Ultimate Fighting Championship (UFC)
US
Valorant
Western
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessRPM International Inc. (NYSE:RPM) Quarterly Earnings Preview

RPM International Inc. (NYSE:RPM) Quarterly Earnings Preview

Add to Favorite
Added to Favorite


Wall Street’s EPS estimate for RPM stands at $1.35, with analysts expecting a slightly lower figure of $1.34, indicating an improvement from last year’s $1.22.
The company’s projected revenue is around $1.79 billion, showcasing its growth trajectory in the specialty coatings and building materials sector.
Key financial ratios such as the P/E ratio of 25.57 and a current ratio of 2.26 highlight RPM’s market valuation and financial stability.

RPM International Inc. (NYSE:RPM) is a global leader in specialty coatings, sealants, and building materials. The company operates in various segments, including industrial, consumer, and specialty products. RPM competes with other major players in the industry, such as Sherwin-Williams and PPG Industries. The company is set to release its quarterly earnings on Tuesday, January 7, 2025.

Wall Street estimates RPM’s earnings per share (EPS) to be $1.35, while analysts anticipate a slightly lower EPS of $1.34. This still marks an improvement from the $1.22 per share reported in the same period last year. The projected revenue is approximately $1.79 billion, reflecting the company’s growth trajectory.

RPM’s financial metrics provide insight into its market valuation. The price-to-earnings (P/E) ratio of 25.57 indicates the price investors are willing to pay for each dollar of earnings. A price-to-sales ratio of 2.17 suggests the market values RPM at over two times its annual sales, while the enterprise value to sales ratio of 2.47 reflects the company’s total valuation relative to its sales.

The enterprise value to operating cash flow ratio of 17.79 shows how RPM’s valuation compares to its cash flow from operations. An earnings yield of 3.91% offers insight into the return on investment for shareholders. RPM’s debt-to-equity ratio of 0.77 indicates a moderate level of debt compared to its equity, suggesting a balanced financial structure.

RPM’s current ratio of 2.26 demonstrates its ability to cover short-term liabilities with short-term assets, highlighting its financial stability. As RPM prepares to announce its second-quarter financial results, these metrics provide a comprehensive view of the company’s financial health and market position.

Subscribe to get Latest News Updates

Latest News

You may like more
more

Sangamo Shares Plummet 56 percent as Pfizer Ends Hemophilia A Gene Therapy Partnership

Sangamo Therapeutics (NASDAQ:SGMO) faced a significant setback as Pfizer...

Astera Labs Downgraded to Market Perform Amid Valuation Concerns

Northland analysts downgraded Astera Labs (NASDAQ:ALAB) from Outperform to...